Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-26 @ 1:41 AM
NCT ID:
NCT03583333
Pre Assignment Details:
Participants were randomized 1:1 to receive either FDC of imipenem/cilastatin (IMI) and relebactam (REL) \[IMI/REL, MK-7655A\], or piperacillin/tazobactam (PIP/TAZ).
Recruitment Details:
This study was conducted at 54 centers in 8 countries.
Study:
NCT03583333
Study Brief:
Results Section:
NCT03583333